Medicine trade tops $100b in 2015, hitting all-time high
Updated: 2016-02-05 08:11
By Wang Wen(China Daily)
|
|||||||||
Employees arrange pills at a workshop owned by Beijing Tong Ren Tang Group Co Ltd, a traditional Chinese medicine maker.[Photo/Xinhua] |
China's trade in medicines hit an all-time high of $102 billion last year.
The latest figures from the China Chamber of Commerce for Import and Export of Medicines and Health Products show the value was a 4.73 percent increase on 2014, and this year total export-import volumes are expected to rise again, by 3 to 5 percent.
Xu Ming, the chamber's deputy director, called the overall growth "healthy and stable", adding, however, that the Chinese export market had slowed.
Medicine imports were worth $46.2 billion, up 7.3 percent, while exports grew a slower 2.7 percent to $56.4 billion.
"That import growth indicates the Chinese domestic market has huge potential, as it is now the second-largest globally after the United States," said Xu.
The weaker export figures were largely indicative of an ongoing global economic slowdown, Xu said, and coupled with a weaker yuan, they put China on the back foot as an international medicine supplier.
Exports to the US performed well, even though some other main markets dropped. Volumes to the US grew 7.72 percent compared with the previous year and it is now China's second-largest medicine export market after Europe, where demand dropped 0.22 percent.
Xu remains positive that Chinese companies are making strong headway in their moves to expand trade abroad.
Some have been expanding through investment and merger, which is often a more complicated route than simply selling their products directly.
"It's astonishing how some Chinese companies have performed so well in overseas investments," Xu said.
One of the sector's most significant developments in 2015 was by a consortium led by Shanghai Fosun Pharmaceutical Group Co Ltd, which bought Ambrx Inc, a US biotechnology company focusing on molecular medicine.
The acquisition group also involved HOPU Jinghua (Beijing) Investment Consultancy Co Ltd, China Everbright Ltd's healthcare fund, and Wuxi PharmaTech, and the purchase included some valuable global biotechnology.
Fosun Pharma's Chairman Chen Qiyu said the acquisition would "produce a dramatic synergistic effect on Fosun's current development system".
Ambrx is now expected to build a global products development center in China, Chen said.
Other moves saw Chinese companies signing agreements with foreign companies to sell their products overseas.
Jiangsu Heng Rui Medicine Co Ltd, for instance, authorized US-based pharmaceutical company Incyte Corp to develop and sell its PD-1 antibody product outside China in September, with the Delaware firm paying $795 million for the right.
- General strike against pension reform brings Greece to standstill
- Madrid airport sounds alarm after bomb threat on Saudi plane
- Obama proposes new oil tax to fund clean transportation
- UN special envoy announces temporary pause of intra-Syrian talks
- Taliban kill 10-year-old hailed as militia hero
- Obama slams anti-Muslim rhetoric during first visit to US mosque
- Kindness walls bringing extra warmth to the needy
- A robot that grabs red envelopes
- Culture Insider: 9 things you may not know about Start of Spring
- Talented artist makes tiny pencil lead sculptures
- Ten most heartwarming stories about Spring Festival Rush
- China's 'Moon Walker' sends back stunning HD photos
- Starbucks, office rents and CEOs form alternative outlook on China
- China's most beautiful wetlands
Most Viewed
Editor's Picks
8 highlights about V-day Parade |
Glimpses of Tibet: Plateaus, people and faith |
Chinese entrepreneurs remain optimistic despite economic downfall |
50th anniversary of Tibet autonomous region |
Tianjin explosions: Deaths, destruction and bravery |
Cinemas enjoy strong first half |
Today's Top News
National Art Museum showing 400 puppets in new exhibition
Finest Chinese porcelains expected to fetch over $28 million
Monkey portraits by Chinese ink painting masters
Beijing's movie fans in for new experience
Obama to deliver final State of the Union speech
Shooting rampage at US social services agency leaves 14 dead
Chinese bargain hunters are changing the retail game
Chinese president arrives in Turkey for G20 summit
US Weekly
Geared to go |
The place to be |